Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TKT: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TKT is a gene implicated in neurodegeneration research. Key relationships include: regulates, inhibits, implicated in. Associated with AD, ALS, AMI. Connected to 52 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | TKT |
| Full Name | Transketolase |
| Chromosome | 3p21.1 |
| Protein Type | Enzyme |
| Function | Transketolase catalyzes transfers of two-carbon units in the non-oxidative PPP: |
| Molecular Weight | 67.8 kDa |
| Amino Acids | 623 aa |
| Pathways | Glycolysis |
| UniProt ID | P29597 |
| NCBI Gene ID | 7086 |
| Ensembl ID | ENSG00000163798 |
| OMIM | 177027 |
| GeneCards | TKT |
| Human Protein Atlas | TKT |
| Associated Diseases | AD, Als, AMI, ARM, cancer, carcinoma |
| Interactions | CANCER, CD8, GAIN, HIF, Hif-1, HIF-1Α |
| KG Connections | 62 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
TKT["TKT"]
Cancer{"Cancer"}
TKT -->|"activates"| Cancer
Carcinoma{"Carcinoma"}
TKT -->|"therapeutic target"| Carcinoma
Ms{"Ms"}
TKT -->|"activates"| Ms
Als{"Als"}
TKT -->|"activates"| Als
ALS{"ALS"}
TKT -->|"activates"| ALS
TKT -->|"regulates"| Carcinoma
Glycolysis(["Glycolysis"])
TKT -->|"activates"| Glycolysis
TIGAR["TIGAR"]
TKT -->|"therapeutic target"| TIGAR
GAIN["GAIN"]
TKT -->|"activates"| GAIN
IDH2["IDH2"]
TKT -->|"therapeutic target"| IDH2
CANCER["CANCER"]
TKT -->|"activates"| CANCER
TKT -->|"regulates"| TIGAR
TIGAR -->|"therapeutic target"| TKT
IDH2 -->|"therapeutic target"| TKT
GAIN -->|"activates"| TKT
HIF["HIF"]
HIF -->|"activates"| TKT
IDH2 -->|"regulates"| TKT
AND["AND"]
AND -->|"regulates"| TKT
style TKT fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| IDH2 | associated_with | entity | 0.85 |
| Poor Prognosis | associated_with | phenotype | 0.80 |
| Glycolysis | activates | pathway | 0.70 |
| Breast Cancer | regulates | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Hepatocellular Carcinoma | inhibits | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Carcinoma | inhibits | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Carcinoma | regulates | disease | 0.65 |
| Senescence | inhibits | disease | 0.65 |
| Hif-1 | activates | protein | 0.60 |
| Sumo | activates | protein | 0.60 |
| HIF-1Α | activates | gene | 0.60 |
| CANCER | regulates | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| Glycolysis | regulates | pathway | 0.60 |
| Blood-Brain Barrier | inhibits | pathway | 0.60 |
| Tumor Microenvironment | inhibits | pathway | 0.60 |
| Metastasis | inhibits | pathway | 0.60 |
| HIF | activates | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| TIGAR | therapeutic_target | gene | 0.60 |
| GAIN | activates | gene | 0.60 |
| IDH2 | therapeutic_target | gene | 0.60 |
| TIGAR | regulates | gene | 0.60 |
| FBP1 | regulates | gene | 0.60 |
| TP53 | regulates | gene | 0.60 |
| PDK1 | regulates | gene | 0.60 |
| ENO1 | regulates | gene | 0.60 |
| CD8 | inhibits | gene | 0.60 |
| IDH2 | regulates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| AMI | implicated_in | disease | 0.50 |
| ARM | implicated_in | disease | 0.50 |
| Ms | implicated_in | disease | 0.50 |
| RA | implicated_in | disease | 0.50 |
| SS | implicated_in | disease | 0.50 |
| cancer | implicated_in | disease | 0.50 |
| AD | implicated_in | disease | 0.50 |
| carcinoma | implicated_in | disease | 0.50 |
| Als | implicated_in | disease | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PGK1 | regulates | gene | 0.60 |
| GAPDH | regulates | gene | 0.60 |
| INFLAMMATION | inhibits | gene | 0.60 |
| TIGAR | therapeutic_target | gene | 0.60 |
| IDH2 | therapeutic_target | gene | 0.60 |
| GAIN | activates | gene | 0.60 |
| TIGAR | regulates | gene | 0.60 |
| IDH2 | expressed_in | entity | 0.60 |
| TIGAR | expressed_in | entity | 0.60 |
| IDH2 | regulates | gene | 0.60 |
| CTPS1 | regulates | gene | 0.60 |
| HIF | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning TKT in their description or question text
No additional research found